These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 36586496)
1. Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF/c-Met Signaling Pathway. Wang B; Liu W; Liu C; Du K; Guo Z; Zhang G; Huang Z; Lin S; Cen B; Tian Y; Yuan Y; Bu J Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):640-654. PubMed ID: 36586496 [TBL] [Abstract][Full Text] [Related]
2. SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling. Qin H; Yang Y; Jiang B; Pan C; Chen W; Diao W; Ding M; Cao W; Zhang Z; Chen M; Gao J; Zhao X; Qiu X; Guo H FEBS J; 2021 Sep; 288(18):5406-5429. PubMed ID: 33705609 [TBL] [Abstract][Full Text] [Related]
3. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells. Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248 [TBL] [Abstract][Full Text] [Related]
4. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Ding X; Ji J; Jiang J; Cai Q; Wang C; Shi M; Yu Y; Zhu Z; Zhang J Cell Death Dis; 2018 Aug; 9(9):867. PubMed ID: 30158543 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954 [TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling. Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515 [TBL] [Abstract][Full Text] [Related]
7. TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms. Fang WB; Mafuvadze B; Yao M; Zou A; Portsche M; Cheng N PLoS One; 2015; 10(8):e0135063. PubMed ID: 26252654 [TBL] [Abstract][Full Text] [Related]
8. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer. Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944 [TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast (CAF) secretomes-induced epithelial-mesenchymal transition on HT-29 colorectal carcinoma cells associated with hepatocyte growth factor (HGF) signalling. Wanandi SI; Hilbertina N; Siregar NC; Abdullah M; Jeo WS J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S18-S24. PubMed ID: 33785936 [TBL] [Abstract][Full Text] [Related]
10. Exploring the association of POSTN Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570 [TBL] [Abstract][Full Text] [Related]
11. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Kwon Y; Smith BD; Zhou Y; Kaufman MD; Godwin AK Oncogene; 2015 Jan; 34(2):144-53. PubMed ID: 24362531 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer associated fibroblasts promote MCF-7 invasion in vitro by secretion of HGF. Chen P; Mo Q; Wang B; Weng D; Wu P; Chen G J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):92-96. PubMed ID: 22282252 [TBL] [Abstract][Full Text] [Related]
14. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166 [TBL] [Abstract][Full Text] [Related]
15. [Tumor microenvironment elicits primary resistance to afatinib through HGF secretion]. Kang XH; Wang LF; Cao F; Fan FT; Xu ZY Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):732-6. PubMed ID: 24378092 [TBL] [Abstract][Full Text] [Related]
16. Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model. Konstorum A; Lowengrub JS J Theor Biol; 2018 Feb; 439():86-99. PubMed ID: 29203124 [TBL] [Abstract][Full Text] [Related]
17. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma. Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targeting of Stromal-Tumor HGF-MET Signaling in an Organotypic Triple-Negative Breast Tumor Model. Singh S; Lamichhane A; Rafsanjani Nejad P; Heiss J; Baumann H; Gudneppanavar R; Leipzig ND; Konopka M; Luker GD; Tavana H Mol Cancer Res; 2022 Jul; 20(7):1166-1177. PubMed ID: 35348758 [TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion. Jia CC; Wang TT; Liu W; Fu BS; Hua X; Wang GY; Li TJ; Li X; Wu XY; Tai Y; Zhou J; Chen GH; Zhang Q PLoS One; 2013; 8(5):e63243. PubMed ID: 23667593 [TBL] [Abstract][Full Text] [Related]
20. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]